Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 702
Selected: 0
NCT IDTitle
NCT01240668Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
NCT01493180Exploratory Study of OPC-12759 Ophthalmic Suspension
NCT05883956A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia
NCT05113953A Trial of Centanafadine Efficacy, Safety, and Tolerability in Adult Subjects With Binge Eating Disorder
NCT01131351Safety and Pharmacokinetics (PK) in Multidrug-Resistant (MDR) Refractive Tuberculosis
NCT00071331EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan
NCT05463770A Clinical Study That Will Assess the Effect of SEP-363856 and Prior Antipsychotic (PA) Standard of Care on Glucose and Regulation of Insulin in Patients With Schizophrenia
NCT01909466Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia
NCT05848700A Clinical Study to Learn if SEP-363856 Has Physical Dependence in Adults With Schizophrenia
NCT02250170Safety and Biomarker of OPB-111077 in Subjects With Advanced Solid Tumor
NCT00110461Aripiprazole in Children and Adolescents With Bipolar I Disorder
NCT03896945Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia
NCT02483169PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study
NCT01074294Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder
NCT03734172Rapid and Accurate Diagnosis of Paediatric TB (RaPaed-AIDA-TB)
NCT00234065Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2)
NCT03828201Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB
NCT01972711Study Assessing SEP-363856 in Male and Female Volunteers With High or Low Schizotype Characteristics
NCT07166783Single Dose of 7.5mg Tolvaptan Phase I Clinical Trial Protocol
NCT02476409Tolvaptan For Worsening Outpatient Heart Failure: Role of Copeptin In Identifying Responders
NCT05923892Phase II Clinical Trial of OPS-2071 in the Treatment of Irritable Bowel Syndrome of Diarrhea Type
NCT03150771Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia
NCT03568500A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic
NCT00202007Efficacy and Safety Study of Aripiprazole to Treat Schizophrenia
NCT01432444Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole
NCT00448357Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen
NCT00569764Effect on Metabolic Parameters of Abilify in SPR
NCT01838681Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
NCT00328367Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory Schizophrenia
NCT01052077Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder
NCT04049825A Phase 1 Trial of OPB-111077 in Combination With Bendamustine and Rituximab in Patients With r/r DLBCL
NCT01481142Adacolumn in Refractory UC Patients Trial
NCT00847860Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White Matter Lesions
NCT00095524Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder
NCT02679469A Single-center, Open-label, Single-dose Study Investigating the Safety, Tolerability, and Pharmacokinetic Properties of Nalmefene 10 mg Tablets in Healthy Japanese Male Subjects
NCT02192554Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
NCT07549581A Study of SEP-380135 in Adults With Schizophrenia or Major Depressive Episode
NCT00545675Abilify in Bipolar Disorder for 24 Weeks Treatment Effectiveness
NCT01043250Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients
NCT04109950A Clinical Study to Evaluate the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia
NCT07767903A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety Disorder
NCT03487770Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Autistic Disorder
NCT01048788A Trial of OPC-41061 in Patients With Hepatic Edema - Investigation of the Safety of Treatment at 7.5 mg Beyond 7 Days and of the Effect of Dose Escalation to 15 mg
NCT02068352A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis
NCT02534038Safety, Tolerability and Efficacy of AVP-786 for the Treatment of Disinhibition
NCT07455084A Study to Detect the Radioactivity of 14C-SEP-380135 in Urine and Feces in Healthy Male Adults
NCT02174835A Phase-1 Study to Assess the Pharmacokinetics, Safety and Tolerability of AVP-786 in Healthy Volunteers
NCT05439148OPC-61815 in Healthy Chinese Male Subjects
NCT04313153Trial Evaluating the Efficacy and Safety of Oral Vadadustat Once Daily (QD) and Three Times Weekly (TIW) for the Maintenance Treatment of Anemia in Hemodialysis Subjects Converting From Erythropoiesis-Stimulating Agents (ESAs)
NCT00731549Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia